Artemisia
Artemisia (Qing Hao) has recently attracted considerable publicity as a possible alternative to anti-malarial drugs following the development of resistant strains of malaria in some parts of the world.
Artemisia has been used as an anti-malarial drug in China for two thousand years, but it has recently been discovered that artemisia also inhibits toxoplasmosis in the test tube (Ou-Yang). It has been suggested that artemisia may also be active against Pneumocystis carinii, but there is no laboratory or clinical evidence to support this view.
References
Ou-Yang K et al. Antimicrobial Agents and Chemotherapy 34:1961-1965, 1990.
latest aidsmap news
- Fluconazole shown to be more effective against cryptococcal meningitis at higher dose
- Promising early results for large-scale study of community-level HIV prevention initiative
- GNP+ launches website documenting global HIV exposure / transmission laws and prosecutions
- Widespread resistance to antiretrovirals among children in the Central African Republic
- Children starting HIV treatment in sub-Saharan Africa have a low risk of death
- Different paediatric responses to antiretroviral therapy in Uganda and the United Kingdom/Ireland may reflect differences in nutrition and access to cotrimoxazole
- Rare abacavir liver side-effects reported
- Abacavir treatment doesn't cause changes in biomarkers linked to heart attack, suggests small study
- Traditional healers could play key role in ART rollout
- HIV testing for mothers and children must expand, UN report shows
